ODAC Calls For Additional EPO Trials To Support Continued Use In Oncology

In the absence of data on approved therapeutic target, panel advises adding warnings from signals in off-label use to label.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet